Coloplast A/S
CLPBF
$57.64
$0.360.62%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.09B | 1.10B | 1.09B | 1.06B | 977.56M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.09B | 1.10B | 1.09B | 1.06B | 977.56M |
| Cost of Revenue | 363.45M | 359.74M | 344.31M | 342.71M | 310.62M |
| Gross Profit | 724.29M | 738.02M | 745.95M | 715.69M | 666.94M |
| SG&A Expenses | 409.36M | 412.11M | 410.73M | 392.15M | 370.43M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -3.53M | -935.20K | -12.53M | -4.11M | -3.95M |
| Total Operating Expenses | 808.28M | 809.41M | 781.51M | 767.11M | 710.81M |
| Operating Income | 279.46M | 288.35M | 308.75M | 291.30M | 266.75M |
| Income Before Tax | -191.01M | 279.16M | 243.58M | 204.14M | 210.32M |
| Income Tax Expenses | -41.92M | 61.41M | 106.52M | 81.68M | 81.67M |
| Earnings from Continuing Operations | -149.10M | 217.74M | 137.07M | 122.45M | 128.65M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -149.10M | 217.74M | 137.07M | 122.45M | 128.65M |
| EBIT | 279.46M | 288.35M | 308.75M | 291.30M | 266.75M |
| EBITDA | 793.69M | 342.12M | 344.35M | 343.47M | 315.27M |
| EPS Basic | -0.66 | 0.97 | 0.61 | 0.54 | 0.57 |
| Normalized Basic EPS | 0.76 | 0.79 | 0.79 | 0.60 | 0.62 |
| EPS Diluted | -0.66 | 0.97 | 0.61 | 0.54 | 0.57 |
| Normalized Diluted EPS | 0.76 | 0.79 | 0.79 | 0.60 | 0.62 |
| Average Basic Shares Outstanding | 225.20M | 225.00M | 225.40M | 225.40M | 225.40M |
| Average Diluted Shares Outstanding | 225.20M | 225.00M | 225.40M | 225.49M | 225.40M |
| Dividend Per Share | 0.77 | -- | 2.82 | 0.00 | 0.71 |
| Payout Ratio | 0.00% | 290.41% | 0.00% | 140.00% | 0.00% |